Centrexion Therapeutics
Signal active
Organization
Contact Information
Overview
Centrexion Therapeutics is a late clinical-stage biopharmaceutical company focusing on identifying, developing, and commercializing non-opioid and non-addictive therapies to address the treatment of chronic pain.
About
Industries
Biotechnology, Health Care, Pharmaceutical
Founded
2013
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Centrexion Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Pharmaceutical sector. The company focuses on Biotechnology and has secured $33.0B in funding across 144 round(s). With a team of 11-50 employees, Centrexion Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Convertible Note - Centrexion Therapeutics, raised $10.5M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
12
Investors
0
Lead Investors
0
Total Funding Amount
$229.2M
Details
4
Centrexion Therapeutics has raised a total of $229.2M in funding over 4 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2018 | Late Stage Venture | 67.0M | ||
| 2016 | Late Stage Venture | 47.6M | ||
| 2013 | Early Stage Venture | 8.8M | ||
| 2013 | Early Stage Venture | 14.7M |
Investors
Centrexion Therapeutics is funded by 15 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Eli Lilly | - | FUNDING ROUND - Eli Lilly | 40.5M |
| Sam Isaly | - | FUNDING ROUND - Sam Isaly | 40.5M |
| Centrexion Therapeutics | - | FUNDING ROUND - Centrexion Therapeutics | 40.5M |
| Centrexion Therapeutics | - | FUNDING ROUND - Centrexion Therapeutics | undefined |
Recent Activity
There is no recent news or activity for this profile.